Edelman to help PhRMA teach public about bioterror

WASHINGTON: As the latest initiative in its plan to help the

government protect the public against bioterrorism, the Pharmaceutical

Research & Manufacturers of America (PhRMA) has hired Edelman's DC

practice to prepare a campaign that will educate doctors and consumers

about biomedical threats.



With PhRMA, Edelman will develop educational materials, including

brochures, newsletter inserts, and a website that will provide

information to doctors and consumers about bio threats. The campaign

will give tips on how to recognize biomedical hazards such as anthrax,

and also list resources that everyone can use to find out more

information.



"Edelman is providing us with extra arms and legs to develop this

initiative," said Chris Molineaux, VP of public affairs for PhRMA.



This is the first time that Edelman's DC practice has worked with the

industry group.



After the anthrax attacks, PhRMA developed a special Task Force on

Emergency Preparedness that includes many top pharmaceutical companies,

including Bayer, Johnson & Johnson, Eli Lilly, Merck, Pfizer, and

GlaxoSmithKline.



Dr. Michael Friedman, former leader of the FDA, leads the industry

initiative as chief medical officer for biomedical preparedness.



The group was created so that the pharmaceutical industry could work

with the government on protecting the public from the threat of

biowarfare.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.